Generex Biotechnology Corp. Stock Price - GNBT

Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Generex Biotechnology Corp. (QB) GNBT OTCMarkets Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.09 -3.41% 2.55 2.69 2.50 2.625 2.64 15:58:27
Bid Price Ask Price Spread Spread % News
2.50 2.55 0.05 1.96% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
94 36,445 $ 2.5745 $ 93,827 116,980 0.65 - 25.30
Last Trade Time Type Quantity Stock Price Currency
16:10:53 average 2,000 $ 2.552 USD

Generex Biotechnology Corp. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 163.89M 64.27M $ 36.33M - - 1.05M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
636.32k $ - 0.00% - -

more financials information »

Generex Biotechnology Corp. News

Loading Messages....

Latest GNBT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GNBT Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week2.552.82.52.687569k0-
1 Month2.162.881.912.3392103k0.3918.06%
3 Months2.353.281.62.4917114k0.28.51%
6 Months1.53.280.882.118986k1.0570.00%
1 Year1.8825.30.652.2986121k0.6735.64%
3 Years625.30.652.333550k-3.45-57.50%
5 Years625.30.652.333550k-3.45-57.50%

Generex Biotechnology Corp. Description

Generex Biotechnology Corporation Generex is a strategic, diversified healthcare holdings company with offerings in a variety of services, diagnostics, medical devices, and pharmaceutical development. The Company's direct-to-patient services support its strategy of all-inclusive access to doctors, diagnostics, therapeutics, and additional health-related services to greatly improve the patient experience in receiving care. On the provider side, Generex's management services remove administrative burdens in multiple provider settings, including private practice and hospital, allowing doctors to devote more time to patient care. Revenue from the Company's subsidiaries will support clinical advancement of its wholly owned therapeutic products with a focus in immunotherapeutics based on stimulating critical members of the immune response, known as T helper cells, and, its proprietary, buccal administered insulin.

Your Recent History
Generex Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.